闪退闪退闪退闪退垃圾软件
垃圾
神经介入资讯
Published by:
Shanghai Brainmed Digital Technology Co
Description
传播、分享神经介入领域的最新技术和理念，规范、创新中国神经介入诊疗水平，致力成为中国神经介入领域最专业的在线教育平台、线上会务平台、远程会诊转诊平台、临床科研等平台。
In-Apps
- 6神贝
- 1.10 ￦
- 68神贝
- 14.00 ￦
- 108神贝
- 22.00 ￦
- 168神贝
- 39.00 ￦
- 268神贝
- 55.00 ￦
- 388神贝
- 88.00 ￦
- 698神贝
- 149.00 ￦
- 998神贝
- 229.00 ￦
- 1998神贝
- 449.00 ￦
Screenshots
神经介入资讯 FAQ
-
Is 神经介入资讯 free?
Yes, 神经介入资讯 is free to download, however it contains in-app purchases or subscription offerings.
-
Is 神经介入资讯 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 神经介入资讯 cost?
神经介入资讯 has several in-app purchases/subscriptions, the average in-app price is 116.23 ￦.
-
What is 神经介入资讯 revenue?
To get estimated revenue of 神经介入资讯 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in South Korea yet.
Ratings History
神经介入资讯 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
神经介入资讯 Competitors
神经介入资讯 Installs
Last 30 days
神经介入资讯 Revenue
Last 30 days神经介入资讯 Revenue and Downloads
Gain valuable insights into 神经介入资讯 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Shanghai Brainmed Digital Technology Co
- Languages
- English
- Recent release
- 1.6.1 (11 months ago )
- Released on
- Oct 18, 2017 (7 years ago )
- Also available in
- China, Hungary, Vietnam, New Zealand, Netherlands, Nigeria, Malaysia, Kazakhstan, Kuwait, South Korea, Italy, Israel, Indonesia, United Arab Emirates, United Kingdom, France, Finland, Algeria, Denmark, Germany, Czechia, Colombia, Austria
- Last Updated
- 4 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.